Teva CEO exits in ongoing crisis of confidence at drugmaker | Reuters
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
Teva CEO Erez Vigodman Steps Down | CHEManager
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Teva Pharmaceutical CEO on Bringing His Company Back from the Brink | Barron's
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
Ambassador views Teva CEO as important player in potential vaccine alliance
Teva CEO reportedly wanted to stay in his job | The Times of Israel
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO Erez Vigodman steps down - Philadelphia Business Journal
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva CEO Erez Vigodman Resigns
Teva CEO Vigodman steps down
Teva CEO: We have to launch new products - Globes
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
President and CEO of North Wales' Teva Pharmaceutical Steps Down
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Haaretz.com
US Congress grills Teva CEO on Copaxone price hikes - Globes
